John C. Pepia - Sep 2, 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role: Principal Accounting Officer
Signature: /s/ Dominic J. Andreano, as Attorney-in-Fact
Stock symbol: MD
Transactions as of: Sep 2, 2021
Transactions value $: -$318,300
Form type: 4
Date filed: 9/3/2021, 04:13 PM
Previous filing: Jun 2, 2021
Next filing: Oct 29, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	-$318K	-10K	-8.28%	$31.83	111K	Sep 2, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $31.63 to $31.92 for a weighted average sales price of $31.83. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	Includes 58 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filed.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $31.63 to $31.92 for a weighted average sales price of $31.83. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 58 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filed.